Category: Insights

5 Steps to Take When Your Drug Patent is About to Expire

There’s no reason to assume that every branded drug will fall victim to the “patent cliff.” Actions taken before drug patent expiration can extend drug life cycles.
The post 5 Steps to Take When Your Drug Patent is About to Expire appeared first on Dru…


Will AI Help Challenge Drug Patents, or Strengthen Them?

Artificial intelligence is allowing chemists to find new way to synthesize drug molecules, and forcing drug developers to shore up their patent strategies.
The post Will AI Help Challenge Drug Patents, or Strengthen Them? appeared first on DrugPatentWa…


Does Drug Patent Evergreening Prevent Generic Entry?

Recently a presentation by an Israeli patent examiner was brought forward in an argument against patent evergreening. In her presentation, the patent examiner claims that patent evergreening has the following…
The post Does Drug Patent Evergreening Pre…


Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements

This article was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Ther Innov Regul Sci. 2019 Jan 7:2168479018811889 under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by…


Review of Drugs Approved via the 505(b)(2) Pathway: Uncovering Drug Development Trends and Regulatory Requirements

This article was originally published by Ingrid Freije, Stéphane Lamouche, and Mario Tanguay in Ther Innov Regul Sci. 2019 Jan 7:2168479018811889 under a Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by…


How to Use Drug Sales Data to Refine Your Channel Strategy and Improve Your Portfolio Management

Historic drug sales data can help with market sizing. By examining sales trends over time you can gauge the attractiveness of the market entry. For patented drugs examining sales trends…
The post How to Use Drug Sales Data to Refine Your Channel Strate…


Inside the mind of an EPO examiner

This article was originally published by Philippe Lahorte in World Patent Information Volume 54, Supplement, September 2018, Pages S18-S22 Under a Creative Commons license. Abstract This article provides an insight…
The post Inside the mind of an EPO e…


DrugPatentWatch Partners with Adis: Helping Drug Companies Make Better Decisions

DrugPatentWatch, a provider of global biopharmaceutical business intelligence, has entered into a partnership with Adis. The partner will enhance Adis’ market-leading platform, bringing together the most relevant information to support…
The post DrugPa…


Branded Generics: What They Are and Why They’re Profitable

Branded generics are generic drugs that have been given proprietary brand names. They have a small, but profitable place in the U.S. pharmaceutical market.
The post Branded Generics: What They Are and Why They’re Profitable appeared first on DrugPatent…


Do NOT follow this link or you will be banned from the site!